UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The use of glycaemic index tables to predict glycaemic index of composite breakfast meals

British journal of nutrition, 2004-06, Vol.91 (6), p.979-989

2004

Volltextzugriff (PDF)

A loss-of-function screen for phosphatases that regulate neurite outgrowth identifies PTPN12 as a negative regulator of TrkB tyrosine phosphorylation

PloS one, 2013-06, Vol.8 (6), p.e65371-e65371

2013

Volltextzugriff (PDF)

Associations between postprandial insulin and blood glucose responses, appetite sensations and energy intake in normal weight and overweight individuals: a meta-analysis of test meal studies

British journal of nutrition, 2007-07, Vol.98 (1), p.17-25

2007

Volltextzugriff (PDF)

Ramucirumab or placebo plus erlotinib in EGFR‐mutated, metastatic non‐small‐cell lung cancer: East Asian subset of RELAY

Cancer science, 2020-12, Vol.111 (12), p.4510-4525

2020

Volltextzugriff (PDF)

Increased postprandial glycaemia, insulinemia, and lipidemia after 10 weeks' sucrose-rich diet compared to an artificially sweetened diet: a randomised controlled trial

Food & nutrition research, 2011-01, Vol.55 (1), p.5961-13

2011

Volltextzugriff (PDF)

Glycemic and insulinemic responses as determinants of appetite in humans

The American journal of clinical nutrition, 2006-12, Vol.84 (6), p.1365-1373

2006

Volltextzugriff (PDF)

Activation of c-Src and Fyn Kinases by Protein-tyrosine Phosphatase RPTPα Is Substrate-specific and Compatible with Lipid Raft Localization

The Journal of biological chemistry, 2008-12, Vol.283 (51), p.35815-35824

2008

Volltextzugriff (PDF)

Determinants of appetite ratings: the role of age, gender, BMI, physical activity, smoking habits, and diet/weight concern

Food & nutrition research, 2011-01, Vol.55 (1), p.7028

2011

Volltextzugriff (PDF)

Pemetrexed in combination with cisplatin versus cisplatin monotherapy in patients with recurrent or metastatic head and neck cancer: final results of a randomized, double-blind, placebo-controlled, phase 3 study

Cancer, 2012-10, Vol.118 (19), p.4694-4705

2012

Volltextzugriff (PDF)

Pemetrexed in combination with cisplatin versus cisplatin monotherapy in patients with recurrent or metastatic head and neck cancer

Cancer, 2012-10, Vol.118 (19), p.4694-4705

2012

Volltextzugriff (PDF)

The use of glycaemic index tables to predict glycaemic index of breakfast meals

British journal of nutrition, 2005-07, Vol.94 (1), p.135-136

2005

Volltextzugriff (PDF)

Patientens oplevelse af at blive mødt og inddraget: The Patient's Experience of Being Met and Involved

Klinisk sygepleje, 2016-08, Vol.30 (3), p.196-208

2016

Volltextzugriff (PDF)

The value of two Collembola species as food for a linyphiid spider

Entomologia experimentalis et applicata, 1999-07, Vol.92 (1), p.29-36

1999

Volltextzugriff (PDF)

Phase III Study of Gemcitabine Plus Docetaxel Compared With Capecitabine Plus Docetaxel for Anthracycline-Pretreated Patients With Metastatic Breast Cancer

Journal of clinical oncology, 2009-04, Vol.27 (11), p.1753-1760

2009

Volltextzugriff (PDF)

Dual EGFR-VEGF Pathway Inhibition: A Promising Strategy for Patients With EGFR-Mutant NSCLC

Journal of thoracic oncology, 2021-02, Vol.16 (2), p.205-215

2021

Volltextzugriff (PDF)

Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial

The lancet oncology, 2019-12, Vol.20 (12), p.1655-1669

2019

Volltextzugriff (PDF)

Ramucirumab Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Untreated Metastatic EGFR-Mutated NSCLC: RELAY Japanese Subset

JTO clinical and research reports, 2021-06, Vol.2 (6), p.100171-100171, Article 100171

2021

Volltextzugriff (PDF)

RELAY Subgroup Analyses by EGFR Ex19del and Ex21L858R Mutations for Ramucirumab Plus Erlotinib in Metastatic Non-Small Cell Lung Cancer

Clinical cancer research, 2021-10, Vol.27 (19), p.5258-5271

2021

Volltextzugriff (PDF)

Abstract CT160: Safety of selpercatinib for RET -altered advanced solid tumors: a post hoc analysis of LIBRETTO-001

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.CT160-CT160

2021

Volltextzugriff (PDF)

RELAY, Ramucirumab Plus Erlotinib Versus Placebo Plus Erlotinib in Patients with Untreated, Epidermal Growth Factor Receptor Mutation-Positive, Metastatic Non-Small-Cell Lung Cancer: Safety Profile and Manageability

Drug safety, 2022-01, Vol.45 (1), p.45-64

2022

Volltextzugriff (PDF)

Activation of c-Src and Fyn Kinases by Protein-tyrosine Phosphatase RPTPα Is Substrate-specific and Compatible with Lipid Raft LocalizationS

The Journal of biological chemistry, 2008-12, Vol.283 (51), p.35815-35824

2008

Volltextzugriff (PDF)

Activation of c-Src and Fyn kinases by protein-tyrosine phosphatase RPTPalpha is substrate-specific and compatible with lipid raft localization

The Journal of biological chemistry, 2008-12, Vol.283 (51), p.35815-35824

2008

Volltextzugriff (PDF)

A phase 1b study of necitumumab in combination with abemaciclib in patients with stage IV non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2019-11, Vol.137, p.136-143

2019

Volltextzugriff (PDF)

Patient-reported outcomes in RELAY, a phase 3 trial of ramucirumab plus erlotinib versus placebo plus erlotinib in untreated EGFR -mutated metastatic non-small-cell lung cancer

Current medical research and opinion, 2020-10, Vol.36 (10), p.1667-1675

2020

Volltextzugriff (PDF)

1 – 25 von 336

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(302)
Mit Volltextzugriff
(289)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(231)
Life Sciences & Biomedicine
(210)
Humans
(162)
Male
(86)
Female
(83)
Adult
(75)
Biological And Medical Sciences
(57)
Middle Aged
(57)
Aged
(41)
Medical Sciences
(41)
Animals
(28)
Endocrinology & Metabolism
(26)
Fundamental And Applied Biological Sciences. Psychology
(25)
Inflammation
(23)
Insulin
(23)
Rheumatology
(23)
Biochemistry & Molecular Biology
(21)
Glucose
(20)
Oncology
(18)
Aged, 80 And Over
(16)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The use of glycaemic index tables to predict glycaemic index of composite breakfast meals

A loss-of-function screen for phosphatases that regulate neurite outgrowth identifies PTPN12 as a negative regulator of TrkB tyrosine phosphorylation

Associations between postprandial insulin and blood glucose responses, appetite sensations and energy intake in normal weight and overweight individuals: a meta-analysis of test meal studies

Ramucirumab or placebo plus erlotinib in EGFR‐mutated, metastatic non‐small‐cell lung cancer: East Asian subset of RELAY

Increased postprandial glycaemia, insulinemia, and lipidemia after 10 weeks' sucrose-rich diet compared to an artificially sweetened diet: a randomised controlled trial

Glycemic and insulinemic responses as determinants of appetite in humans

PointBreak: A Randomized Phase III Study of Pemetrexed Plus Carboplatin and Bevacizumab Followed by Maintenance Pemetrexed and Bevacizumab Versus Paclitaxel Plus Carboplatin and Bevacizumab Followed by Maintenance Bevacizumab in Patients With Stage IIIB or IV Nonsquamous Non–Small-Cell Lung Cancer

Activation of c-Src and Fyn Kinases by Protein-tyrosine Phosphatase RPTPα Is Substrate-specific and Compatible with Lipid Raft Localization

Determinants of appetite ratings: the role of age, gender, BMI, physical activity, smoking habits, and diet/weight concern

Pemetrexed in combination with cisplatin versus cisplatin monotherapy in patients with recurrent or metastatic head and neck cancer: final results of a randomized, double-blind, placebo-controlled, phase 3 study

Pemetrexed in combination with cisplatin versus cisplatin monotherapy in patients with recurrent or metastatic head and neck cancer

The use of glycaemic index tables to predict glycaemic index of breakfast meals

Patientens oplevelse af at blive mødt og inddraget: The Patient's Experience of Being Met and Involved

The value of two Collembola species as food for a linyphiid spider

Phase III Study of Gemcitabine Plus Docetaxel Compared With Capecitabine Plus Docetaxel for Anthracycline-Pretreated Patients With Metastatic Breast Cancer

Dual EGFR-VEGF Pathway Inhibition: A Promising Strategy for Patients With EGFR-Mutant NSCLC

Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial

Ramucirumab Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Untreated Metastatic EGFR-Mutated NSCLC: RELAY Japanese Subset

RELAY Subgroup Analyses by EGFR Ex19del and Ex21L858R Mutations for Ramucirumab Plus Erlotinib in Metastatic Non-Small Cell Lung Cancer

Abstract CT160: Safety of selpercatinib for RET -altered advanced solid tumors: a post hoc analysis of LIBRETTO-001

RELAY, Ramucirumab Plus Erlotinib Versus Placebo Plus Erlotinib in Patients with Untreated, Epidermal Growth Factor Receptor Mutation-Positive, Metastatic Non-Small-Cell Lung Cancer: Safety Profile and Manageability

Activation of c-Src and Fyn Kinases by Protein-tyrosine Phosphatase RPTPα Is Substrate-specific and Compatible with Lipid Raft LocalizationS

Activation of c-Src and Fyn kinases by protein-tyrosine phosphatase RPTPalpha is substrate-specific and compatible with lipid raft localization

A phase 1b study of necitumumab in combination with abemaciclib in patients with stage IV non-small cell lung cancer

Patient-reported outcomes in RELAY, a phase 3 trial of ramucirumab plus erlotinib versus placebo plus erlotinib in untreated EGFR -mutated metastatic non-small-cell lung cancer

Suchergebnisse filtern